Dr. Boyang Zhang is an Assistant Professor of Chemical Engineering at McMaster University. His lab uses advanced biofabrication techniques to build human micro-tissue models for predictive drug discovery and to construct functional macro-tissues for tissue regeneration in patients. He talks about building microfluidic devices for biological applications and using machine learning to study organoid morphology. He also talks about his team's high-throughput system for vascularizing tissue spheroids and his experience starting a company to commercialize this technology.

In this special episode, Daylon and Arun chat with Drs. Jason Goldsmith and Brenda Raud, the hosts of The Immunology Podcast. Recorded in-person and led by Dr. Nicole Quinn from STEMCELL Technologies, the four hosts discuss the impact that podcasting has had on their careers and how it can make science and scientists more accessible. They also talk about the future of science communication and advice for young scientists pursuing careers in academia and industry.

Dr. Clive Svendsen is the Executive Director of the Regenerative Medicine Institute at Cedars-Sinai. His lab uses stem cells to develop models and treatments for neurodegenerative diseases. He talks about using stem cells to model spinal muscular atrophy and the blood-brain barrier, and his cell-gene therapy trial for ALS.

Dr. Shuibing Chen is the Kilts Family Professor of Surgery at Weill Cornell Medicine. Her lab uses hiPSCs and ESCs for disease modeling and drug screening, with a focus on diabetes and infectious diseases such as Zika and SARS-CoV-2. She talks about her recent genome-wide association study in a dish, the role of philanthropic funding in stem cell research, and the role of industry partnerships in translational research.

Dr. Paola Arlotta is the Golub Family Professor of Stem Cell and Regenerative Biology at Harvard University. She is interested in understanding the molecular laws that govern the birth, differentiation, and assembly of the human brain’s cerebral cortex. She talks about using organoids to study the genetics of autism. She also discusses single-cell sequencing of brain organoids and how to make single-cell sequencing methods and data more accessible.

Dr. Jacob Hanna is an Associate Professor at the Weizmann Institute of Science and investigates cellular reprogramming and embryogenesis. This episode features a discussion on the challenges of growing embryo models in a roller culture system and the feasibility of making human gametes. Dr. Hanna also talks about launching the startup, Renewal Bio, the ethical discussions surrounding stem cell-derived embryos, and creating a more inclusive and equitable scientific community.

Dr. Stefan Irion is the Senior Vice President of Research at BlueRock Therapeutics, a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. He talks about the company's Parkinson's disease trial and the challenges of genetically manipulating stem cells. He also discusses his journey from physician to scientist and his personal connection to Parkinson's disease.

Dr. Jun Wu is an Assistant Professor at the University of Texas Southwestern. The Wu lab uses interspecies chimeras to study fundamental biology: conserved and divergent developmental programs, determination of body and organ size, species barriers, and cancer resistance. They are also working to develop new applications for regenerative medicine. He talks about developmental compatibility between species, and the similarities and differences between blastoid models and blastocyts. He also discusses the challenges of growing human cells in animals, and human-monkey chimeric embryos.

Dr. Edward Grow is an Assistant Professor at the University of Texas, Southwestern. His lab studies reproductive biology, specifically the development of the egg and subsequently the fertilized embryo. He talks about regulating totipotency in ESCs, retroviral reactivation, and ex vivo culturing of follicles and oocytes.

Dr. Prisca Liberali is Senior Group Leader at the Friedrich Miescher Institute for Biomedical Research and an Assistant Professor at the University of Basel. Her research aims to understand the collective properties of organoid systems and their patterns, including how these systems allow systematic perturbation by established methods for modulating gene expression. She studies self-organization, symmetry breaking, intestinal organoid development, gastruloids, and mechanosensing mechanisms.